Abstract:background Oral lichen planus is common oral mucosal lesions with several predisposing factors, but with poorly identified etiology. Stressor factors could be one of etiological causes for eruption of the lesion and/or a predisposing factor for its appearance, aggravating the excited lesion. The aim of this study to evaluate certain circumstances that were passed on Iraqi population that may be related to elevated OLP incidence in Iraq. Material and method One hundred twenty-nine clinical charts for oral liche… Show more
“…Before and after treatment, the salivary levels of interleukin-6 were assessed in each patient and the levels found to be higher after PRP treatment; Table (2). in relation to the location of the lesion, its size, the phenotype of the lesion, colour change, and signs or symptoms that the patient was experiencing the levels of IL-6 were compared.…”
Section: Interleukin-6 Level Before and After Prp Injectionsmentioning
confidence: 99%
“…Oral lichen planus (OLP) is a chronic inflammatory lesion of the oral mucosae, its related to aberrant cellular immunity (1), Genetics, psychological state and infectious agents may act as causes and /or triggers (2). It's found that all the possible causes of OLP lesion production have the capacity to modulate the oxidative status (3), and this is approved by the decreased salivary anti-oxidant capacity in OLP patients (4).…”
Background: Interleukin-6 (IL-6) is a cytokine that has several functions, including stimulating growth and inhibiting cell death. It has the potential to operate as a biomarker for the accurate prediction of disease severity and activity, platelets-rich plasma was used in the treatment of oral lichen planus and can change the salivary IL-6 level.
Objectives: To study the clinical outcome of intralesional platelets-rich plasma in patients with oral lichen planus and to measure salivary IL-6 levels before and after the treatment with platelets-rich plasma were the aims of this study.
Subjects and Methods: In this clinical trial, for each patient a standardized case sheet was filled including demography, social, medical, and medication history. Before receiving, each patient was examined for phenotype, color, size, and site of oral lichen planus lesions. Patient's salivary samples were taken between 8 and 11 a.m. Three to four milliliters of saliva was obtained from each patient. The ELISA kit for IL-6 using sandwich-ELISA technique, to measure salivary IL-6 before and after PRP injections.
Results: Thirteen oral lichen planus patients were took part in this study, six males (46.2%) and seven females (53.8%). The patients were between 32 and 91 years of age, with a mean age of 60.2(±13.9) years. All symptomatic and most of the hyperemic ones showed improvement after PRP injections, while the size of the lesions was resistant to change. Mean salivary IL-6 was 44.27 pg/mL (±43.24) before PRP injections and (69.74±59.86 pg/mL) after PRP injections. No significant difference was found, however IL-6 was higher after PRP injections. In relation to color changes after PRP, there was a significant changes in IL-6 level compared with that before PRP injections. Similarly, a significant relation was found between IL-6 level and signs and symptoms; pain and burning sensation. No association was found in salivary IL-6 level in relation to lesion phenotype, size, and location.
Conclusion: All symptomatic OLP lesions that were treated with intralesional PRP responded very well, similarly almost all hyperemic lesions turned into normal mucosal color after completing the course of treatment. The majority of OLP lesions showed an increased salivary IL-6 levels after PRP treatment.
“…Before and after treatment, the salivary levels of interleukin-6 were assessed in each patient and the levels found to be higher after PRP treatment; Table (2). in relation to the location of the lesion, its size, the phenotype of the lesion, colour change, and signs or symptoms that the patient was experiencing the levels of IL-6 were compared.…”
Section: Interleukin-6 Level Before and After Prp Injectionsmentioning
confidence: 99%
“…Oral lichen planus (OLP) is a chronic inflammatory lesion of the oral mucosae, its related to aberrant cellular immunity (1), Genetics, psychological state and infectious agents may act as causes and /or triggers (2). It's found that all the possible causes of OLP lesion production have the capacity to modulate the oxidative status (3), and this is approved by the decreased salivary anti-oxidant capacity in OLP patients (4).…”
Background: Interleukin-6 (IL-6) is a cytokine that has several functions, including stimulating growth and inhibiting cell death. It has the potential to operate as a biomarker for the accurate prediction of disease severity and activity, platelets-rich plasma was used in the treatment of oral lichen planus and can change the salivary IL-6 level.
Objectives: To study the clinical outcome of intralesional platelets-rich plasma in patients with oral lichen planus and to measure salivary IL-6 levels before and after the treatment with platelets-rich plasma were the aims of this study.
Subjects and Methods: In this clinical trial, for each patient a standardized case sheet was filled including demography, social, medical, and medication history. Before receiving, each patient was examined for phenotype, color, size, and site of oral lichen planus lesions. Patient's salivary samples were taken between 8 and 11 a.m. Three to four milliliters of saliva was obtained from each patient. The ELISA kit for IL-6 using sandwich-ELISA technique, to measure salivary IL-6 before and after PRP injections.
Results: Thirteen oral lichen planus patients were took part in this study, six males (46.2%) and seven females (53.8%). The patients were between 32 and 91 years of age, with a mean age of 60.2(±13.9) years. All symptomatic and most of the hyperemic ones showed improvement after PRP injections, while the size of the lesions was resistant to change. Mean salivary IL-6 was 44.27 pg/mL (±43.24) before PRP injections and (69.74±59.86 pg/mL) after PRP injections. No significant difference was found, however IL-6 was higher after PRP injections. In relation to color changes after PRP, there was a significant changes in IL-6 level compared with that before PRP injections. Similarly, a significant relation was found between IL-6 level and signs and symptoms; pain and burning sensation. No association was found in salivary IL-6 level in relation to lesion phenotype, size, and location.
Conclusion: All symptomatic OLP lesions that were treated with intralesional PRP responded very well, similarly almost all hyperemic lesions turned into normal mucosal color after completing the course of treatment. The majority of OLP lesions showed an increased salivary IL-6 levels after PRP treatment.
“…''An oral mucosal illness with an unknown cause called oral lichen planus (OLP) is a chronic inflammatory T-cell-mediated condition'' [3]''. ''Infectious agents, psychological conditions, and genetic factors can all operate as causes or triggers'' [4]''. ''It has been discovered that all potential causes of OLP lesion generation have the ability to alter the oxidative status'' [5],''and this is supported by the fact that OLP patients have lower salivary anti-oxidant capability'' [6]''.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.